OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry
C. A. Isnardi, Karen Roberts, Verónica Saurit, et al.
Clinical Rheumatology (2022) Vol. 42, Iss. 2, pp. 563-578
Open Access | Times Cited: 16
C. A. Isnardi, Karen Roberts, Verónica Saurit, et al.
Clinical Rheumatology (2022) Vol. 42, Iss. 2, pp. 563-578
Open Access | Times Cited: 16
Showing 16 citing articles:
Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review
Andreea-Iulia Vlădulescu-Trandafir, Violeta‐Claudia Bojincă, Constantin Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11149-11149
Open Access | Times Cited: 4
Andreea-Iulia Vlădulescu-Trandafir, Violeta‐Claudia Bojincă, Constantin Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11149-11149
Open Access | Times Cited: 4
Unraveling the Impact of COVID-19 on Rheumatoid Arthritis: Insights from Two Romanian Hospitals—Preliminary Results
Andreea-Iulia Vlădulescu-Trandafir, Gelu Onose, Constantin Munteanu, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2145-2145
Open Access | Times Cited: 3
Andreea-Iulia Vlădulescu-Trandafir, Gelu Onose, Constantin Munteanu, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2145-2145
Open Access | Times Cited: 3
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases
Kévin Chevalier, Michaël Génin, Thomas Petit-Jean, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Kévin Chevalier, Michaël Génin, Thomas Petit-Jean, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Global Perspective on the Impact of the COVID ‐19 Pandemic on Rheumatology and Health Equity
Evelyn Hsieh, Dzifa Dey, Rebecca Grainger, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 22-31
Closed Access | Times Cited: 8
Evelyn Hsieh, Dzifa Dey, Rebecca Grainger, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 22-31
Closed Access | Times Cited: 8
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 12, pp. 3375-3385
Open Access | Times Cited: 8
Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 12, pp. 3375-3385
Open Access | Times Cited: 8
Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report
Victoria Overbeck, Bradford P. Taylor, Jacquelyn Turcinovic, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23699-e23699
Open Access | Times Cited: 6
Victoria Overbeck, Bradford P. Taylor, Jacquelyn Turcinovic, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23699-e23699
Open Access | Times Cited: 6
Meta‐analysis reveals that rheumatoid arthritis is associated with worse clinical outcomes among patients with COVID‐19
Guangmin Zhang, Jiane Liu, Jing Wang, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 2
Closed Access | Times Cited: 1
Guangmin Zhang, Jiane Liu, Jing Wang, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 2
Closed Access | Times Cited: 1
Association of immunomodulatory therapies with COVID-19 mortality in rheumatoid arthritis: An analysis of the FDA adverse event reporting system
Bing Li, Deng Huijie, Chen Yan, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 4, pp. 451-455
Open Access | Times Cited: 1
Bing Li, Deng Huijie, Chen Yan, et al.
Intelligent Pharmacy (2024) Vol. 2, Iss. 4, pp. 451-455
Open Access | Times Cited: 1
Humoral and T Cell Response to SARS‐CoV ‐2 Vaccination in Patients With Rheumatoid Arthritis
C. A. Isnardi, M. Landi, Leonel Cruces, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 120-130
Open Access | Times Cited: 4
C. A. Isnardi, M. Landi, Leonel Cruces, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 120-130
Open Access | Times Cited: 4
Seguridad de las drogas biológicas y sintéticas dirigidas utilizadas en pacientes con enfermedades reumáticas inmunomediadas. Datos del registro BIOBADASAR 3.0
C. A. Isnardi, Karen Roberts, Ida Elena Exeni, et al.
Revista Argentina de Reumatología (2023) Vol. 34, Iss. 1, pp. 1-2
Open Access | Times Cited: 3
C. A. Isnardi, Karen Roberts, Ida Elena Exeni, et al.
Revista Argentina de Reumatología (2023) Vol. 34, Iss. 1, pp. 1-2
Open Access | Times Cited: 3
Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3339-3355
Closed Access | Times Cited: 2
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3339-3355
Closed Access | Times Cited: 2
Risk predictors for adverse COVID-19 outcomes in Latin American patients with autoimmune rheumatic diseases: A multicentre study in Ecuador and Mexico
Santiago Andrés Guzmán García, Goethe Sacoto-Flores, Johanna Román-Bermeo, et al.
Revista Colombiana de Reumatología (2024)
Closed Access
Santiago Andrés Guzmán García, Goethe Sacoto-Flores, Johanna Román-Bermeo, et al.
Revista Colombiana de Reumatología (2024)
Closed Access
Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil
Marco Ulises Martínez‐Martínez, C. A. Isnardi, D. Alpizar-Rodriguez, et al.
Advances in Rheumatology (2024) Vol. 64, Iss. 1
Open Access
Marco Ulises Martínez‐Martínez, C. A. Isnardi, D. Alpizar-Rodriguez, et al.
Advances in Rheumatology (2024) Vol. 64, Iss. 1
Open Access
Características clínicas y evolución de la infección por SARS-CoV-2 en pacientes con lupus eritematoso sistémico en Argentina: datos del registro nacional SAR-COVID
C. A. Isnardi, Karen Roberts, Yohana Tissera, et al.
Revista Argentina de Reumatología (2023) Vol. 33, Iss. 4
Open Access
C. A. Isnardi, Karen Roberts, Yohana Tissera, et al.
Revista Argentina de Reumatología (2023) Vol. 33, Iss. 4
Open Access
Reply
C. A. Isnardi, M. Landi, Guillermo J. Pons‐Estel, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 4, pp. 583-584
Closed Access
C. A. Isnardi, M. Landi, Guillermo J. Pons‐Estel, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 4, pp. 583-584
Closed Access
SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey
Ramnath Misra, Debdutta Bhattacharya, Sakir Ahmed, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 81-87
Closed Access
Ramnath Misra, Debdutta Bhattacharya, Sakir Ahmed, et al.
Rheumatology International (2023) Vol. 44, Iss. 1, pp. 81-87
Closed Access
